Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133705 · ClinicalTrials.gov registry record · Phase 3
Trial of Mifepristone for Fibroids
A Phase 3 study of Leiomyoma, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 3
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT00133705: Completed Phase 3 study of Leiomyoma, sponsored by University of Rochester.
NCT00133705 is a Phase 3 study of Leiomyoma that has completed, run by University of Rochester. The registered enrollment target is 70 participants, below the 97-participant average among 8 other Leiomyoma trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00133705, a Phase 3 study of Leiomyoma, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to determine if low-dose mifepristone benefits women with symptomatic fibroids.
Primary Outcome
Uterine volume is measured in mLs
Conditions Studied
Interventions
- DRUG Mifepristone
- DRUG Inert Capsule
Study Locations (1)
New York
- University of Rochester School of Medicine & Dentistry - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2003-07 |
| Est. Completion | 2010-06 |
| Phase | Phase 3 |
What the finished NCT00133705 record still lists
NCT00133705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 97-participant average among 8 other Leiomyoma trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Leiomyoma appearing as the primary indexed condition, and to 2 interventions - of which Mifepristone is the first listed.
NCT00133705 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00133705 about?
NCT00133705 is a clinical study titled "Trial of Mifepristone for Fibroids". The purpose of this trial is to determine if low-dose mifepristone benefits women with symptomatic fibroids.
What is the current status of trial NCT00133705?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 70 participants. The study started on 2003-07. Estimated completion is 2010-06.
What conditions does trial NCT00133705 study?
This clinical trial studies the following conditions: Leiomyoma.
What interventions are being tested in trial NCT00133705?
The interventions under investigation include: Mifepristone (DRUG), Inert Capsule (DRUG).
Who is sponsoring clinical trial NCT00133705?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00133705 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leiomyoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00133705's enrollment target sits among peer trials
70 6th of 8 higher than 3 of 8 other Leiomyoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Leiomyoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
COMPLETED · Phase 3
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
RECRUITING
-
Effects of Simvastatin on Uterine Leiomyoma Size
RECRUITING · Phase 2
-
Prescription of Letrozole for Uterine Myoma
RECRUITING · Phase 4
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia